Strand Therapeutics snags $6 mln seed
Cambridge, Massachusetts-based Strand Therapeutics Inc., a developer of gene therapies powered by synthetic biology, has raised $6 million in seed funding. Playground Global led the round.
4 June 2019•1 min read
Cambridge, Massachusetts-based Strand Therapeutics Inc., a developer of gene therapies powered by synthetic biology, has raised $6 million in seed funding. Playground Global led the round.
